Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
31.32 USD | -1.88% | +2.09% | +2.15% |
May. 09 | RBC Lifts Price Target on Omega Healthcare Investors to $32 From $31, Keeps Sector Perform Rating | MT |
May. 03 | Transcript : Omega Healthcare Investors, Inc., Q1 2024 Earnings Call, May 03, 2024 |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- The group's activity appears highly profitable thanks to its outperforming net margins.
- The company is one of the best yield companies with high dividend expectations.
- The opinion of analysts covering the stock has improved over the past four months.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- According to forecast, a sluggish sales growth is expected for the next fiscal years.
- The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
- The company benefits from high valuations in earnings multiples.
- Based on current prices, the company has particularly high valuation levels.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Specialized REITs
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+2.15% | 7.89B | B | ||
+10.86% | 60.91B | A- | ||
-5.32% | 19.58B | A- | ||
-3.84% | 13.74B | A | ||
-7.31% | 5.99B | B- | ||
+12.91% | 3.62B | C- | ||
-7.31% | 3.13B | B+ | ||
+2.65% | 2.97B | C | ||
+15.65% | 2.85B | C- | ||
-17.23% | 2.43B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- OHI Stock
- Ratings Omega Healthcare Investors, Inc.